Stanford University School of Medicine

Sixty percent of maternal deaths in the United States are preventable.

The study was designed to find out exactly what effects the vaccine, marketed by Pfizer Inc., has on the numerous components of the immune response

The second shot stimulated a multiple fold rise in antibody levels, terrific T-cell response, which was absent after the first shot, and enhanced innate immune response.

Viewpoint Molecular Targeting, Inc. a radiopharmaceutical company developing precision lead-212-based -particle oncology therapeutics and complementary diagnostic imaging agents, today announced the appointment of Charles Link, M.D., FACP to its Board of Directors

Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company developing novel therapies for diseases related to chronic glucose imbalance, today announced the addition of Quan Dong Nguyen, MD, MSc, FAAO, FARVO to its Scientific Advisory Board.